Vaccine in National Immunization Programme Update October 2018

Countries with Hib vaccine in the national immunization programme; Introduced* to date: Afghanistan Albania Algeria Andorra Angola Antigua and Barbuda Argentina Armenia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belgium Belize Benin Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Darussalam Bulgaria Burkina Faso Burundi Cabo Verde Cambodia Cameroon Canada Central African Republic Chad Chile Colombia Comoros Congo Cook Islands Costa Rica Côte d'Ivoire Croatia Cuba Cyprus Czech Republic Democratic People's Republic of Korea Democratic Republic of the Congo Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Greece Grenada Guatemala Guinea Guinea-Bissau Guyana Haiti Honduras Hungary Iceland India Indonesia Iran (Islamic Republic of) Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libya Lithuania Luxembourg Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Micronesia (Federated States of ) Monaco Mongolia Montenegro Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Zealand Nicaragua Niger Nigeria Niue Norway Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Qatar Republic of Korea Republic of Moldova Romania Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Sudan Spain Sri Lanka Sudan Suriname Swaziland Sweden Switzerland Syrian Arab Republic Tajikistan The former Yugoslav Republic of Macedonia Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United Republic of Tanzania United States of America Uruguay Uzbekistan Vanuatu Venezuela Viet Nam Yemen Zambia Zimbabwe Partial introductions: Belarus No planned introduction: Not Available, Not Introduced/No Plans: China, Russian Federation, Thailand

Countries with Pneumococcal Conjugate vaccine in the national immunization programme; and planned introductions in 2018 Introduced* to date: Afghanistan Albania Algeria Andorra Angola Argentina Armenia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belgium Benin Bolivia Botswana Brazil Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Central African Republic Chile Colombia Congo Costa Rica Côte d'Ivoire Cyprus Democratic Republic of the Congo Denmark Djibouti Dominican Republic Ecuador El Salvador Eritrea Ethiopia Fiji Finland France Gambia Georgia Germany Ghana Greece Guatemala Guinea-Bissau Guyana Honduras Hungary Iceland Iraq Ireland Israel Italy Japan Kazakhstan Kenya Kiribati Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libya Lithuania Luxembourg Madagascar Malawi Mali Marshall Islands Mauritania Mauritius Mexico Micronesia (Federated States of ) Monaco Morocco Mozambique Myanmar Namibia Nepal Netherlands New Zealand Nicaragua Niger Niue Norway Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Poland Portugal Qatar Republic of Korea Republic of Moldova Romania Russian Federation Rwanda San Marino Sao Tome and Principe Saudi Arabia Senegal Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands South Africa Sudan Swaziland Sweden Switzerland Togo Trinidad and Tobago Turkey Uganda United Arab Emirates United Kingdom United Republic of Tanzania United States of America Uruguay Uzbekistan Venezuela Yemen Zambia Zimbabwe Partial introductions: Belarus India Indonesia Mongolia Nigeria Philippines Planned introductions in 2018: Grenada Haiti Not Available, Not Introduced/No Plans: Antigua and Barbuda Belize Bhutan Bosnia and Herzegovina Brunei Darussalam Cabo Verde Chad China Comoros Cook Islands Croatia Cuba Czech Republic Democratic People's Republic of Korea Dominica Egypt Equatorial Guinea Estonia Gabon Guinea Iran (Islamic Republic of) Jamaica Jordan Malaysia Maldives Malta Montenegro Nauru Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa Serbia Somalia South Sudan Spain Sri Lanka Suriname Syrian Arab Republic Tajikistan Thailand The former Yugoslav Republic of Macedonia Timor-Leste Tonga Tunisia Turkmenistan Tuvalu Ukraine Vanuatu Viet Nam

Countries with Rotavirus vaccine in the national immunization programme; and planned introductions in 2018 Introduced* to date: Afghanistan Angola Argentina Armenia Australia Austria Bahamas Bahrain Belgium Bolivia Botswana Brazil Burkina Faso Burundi Cameroon Canada Colombia Congo Côte d'Ivoire Djibouti Dominican Republic Ecuador El Salvador Eritrea Estonia Ethiopia Fiji Finland Gambia Georgia Germany Ghana Greece Guatemala Guinea-Bissau Guyana Haiti Honduras Iraq Ireland Israel Jordan Kenya Kiribati Kuwait Latvia Lesotho Liberia Libya Luxembourg Madagascar Malawi Mali Marshall Islands Mauritania Mauritius Mexico Micronesia (Federated States of ) Morocco Mozambique Namibia New Zealand Nicaragua Niger Niue Norway Pakistan Palau Panama Paraguay Peru Qatar Republic of Moldova Rwanda Sao Tome and Principe Saudi Arabia Senegal Seychelles Sierra Leone South Africa Sudan Swaziland Tajikistan Togo Uganda United Arab Emirates United Kingdom United Republic of Tanzania United States of America Uzbekistan Venezuela Yemen Zambia Zimbabwe Partial introductions: India Italy Russian Federation Sweden Thailand Planned introductions in 2018: Benin Central African Republic Democratic Republic of the Congo Gabon Nepal Not Available, Not Introduced/No Plans: Albania Algeria Andorra Antigua and Barbuda Azerbaijan Bangladesh Barbados Belarus Belize Bhutan Bosnia and Herzegovina Brunei Darussalam Bulgaria Cabo Verde Cambodia Chad Chile China Comoros Cook Islands Costa Rica Croatia Cuba Cyprus Czech Republic Democratic People's Republic of Korea Denmark Dominica Egypt Equatorial Guinea France Grenada Guinea Hungary Iceland Indonesia Iran (Islamic Republic of) Jamaica Japan Kazakhstan Kyrgyzstan Lao People's Democratic Republic Lebanon Lithuania Malaysia Maldives Malta Monaco Mongolia Montenegro Myanmar Nauru Netherlands Nigeria Oman Papua New Guinea Philippines Poland Portugal Republic of Korea Romania Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa San Marino Serbia Singapore Slovakia Slovenia Solomon Islands Somalia South Sudan Spain Sri Lanka Suriname Switzerland Syrian Arab Republic The former Yugoslav Republic of Macedonia Timor-Leste Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Tuvalu Ukraine Uruguay Vanuatu Viet Nam

Countries with HPV vaccine in the national immunization programme; and planned introductions in 2018 Introduced* to date: Andorra Antigua and Barbuda Argentina Armenia Australia Austria Bahamas Barbados Belgium Belize Bhutan Bolivia Botswana Brazil Brunei Darussalam Canada Chile Colombia Cook Islands Croatia Cyprus Czech Republic Denmark Dominican Republic Ecuador Estonia Fiji Finland France Germany Greece Guatemala Guyana Honduras Hungary Iceland Ireland Israel Italy Jamaica Japan Latvia Libya Lithuania Luxembourg Malaysia Malta Marshall Islands Mauritius Mexico Micronesia (Federated States of ) Monaco Netherlands New Zealand Norway Palau Panama Paraguay Peru Portugal Republic of Korea Republic of Moldova Rwanda Saint Vincent and the Grenadines San Marino Sao Tome and Principe Seychelles Singapore Slovenia South Africa Spain Sri Lanka Suriname Sweden Switzerland Thailand The former Yugoslav Republic of Macedonia Trinidad and Tobago Turkmenistan Uganda United Kingdom United Republic of Tanzania United States of America Uruguay Zimbabwe Partial introductions: Georgia India Indonesia Philippines Russian Federation United Arab Emirates Planned introductions in 2018: Ethiopia Grenada Maldives Mauritania Saint Kitts and Nevis Senegal Not Available, Not Introduced/No Plans: Afghanistan Albania Algeria Angola Azerbaijan Bahrain Bangladesh Belarus Benin Bosnia and Herzegovina Bulgaria Burkina Faso Burundi Cabo Verde Cambodia Cameroon Central African Republic Chad China Comoros Congo Costa Rica Côte d'Ivoire Cuba Democratic People's Republic of Korea Democratic Republic of the Congo Djibouti Dominica Egypt El Salvador Equatorial Guinea Eritrea Gabon Gambia Ghana Guinea Guinea-Bissau Haiti Iran (Islamic Republic of) Iraq Jordan Kazakhstan Kenya Kiribati Kuwait Kyrgyzstan Lao People's Democratic Republic Lebanon Lesotho Liberia Madagascar Malawi Mali Mongolia Montenegro Morocco Mozambique Myanmar Namibia Nauru Nepal Nicaragua Niger Nigeria Niue Oman Pakistan Papua New Guinea Poland Qatar Romania Saint Lucia Samoa Saudi Arabia Serbia Sierra Leone Slovakia Solomon Islands Somalia South Sudan Sudan Swaziland Syrian Arab Republic Tajikistan Timor-Leste Togo Tonga Tunisia Turkey Tuvalu Ukraine Uzbekistan Vanuatu Venezuela Viet Nam Yemen Zambia

Countries using Measles Second Dose vaccine to date; and planned introductions in 2018 Introduced* to date: Afghanistan Albania Algeria Andorra Angola Antigua and Barbuda Argentina Armenia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Bhutan Bosnia and Herzegovina Botswana Brazil Brunei Darussalam Bulgaria Burkina Faso Burundi Cabo Verde Cambodia Canada Chile China Colombia Cook Islands Costa Rica Croatia Cuba Cyprus Czech Republic Democratic People's Republic of Korea Denmark Djibouti Dominica Ecuador Egypt El Salvador Eritrea Estonia Fiji Finland France Gambia Georgia Germany Ghana Greece Grenada Guatemala Guyana Haiti Hungary Iceland India Indonesia Iran (Islamic Republic of) Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Libya Lithuania Luxembourg Malawi Malaysia Maldives Malta Marshall Islands Mauritius Mexico Micronesia (Federated States of ) Monaco Mongolia Montenegro Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Zealand Nicaragua Niger Niue Norway Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Qatar Republic of Korea Republic of Moldova Romania Russian Federation Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands South Africa Spain Sri Lanka Sudan Suriname Swaziland Sweden Switzerland Syrian Arab Republic Tajikistan Thailand The former Yugoslav Republic of Macedonia Timor-Leste Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Tuvalu Ukraine United Arab Emirates United Kingdom United Republic of Tanzania United States of America Uruguay Uzbekistan Venezuela Viet Nam Yemen Zambia Zimbabwe Partial introductions: Planned introductions in 2018: Ethiopia Not Available, Not Introduced/No Plans: Benin Bolivia Cameroon Central African Republic Chad Comoros Congo Côte d'Ivoire Democratic Republic of the Congo Dominican Republic Equatorial Guinea Gabon Guinea Guinea-Bissau Honduras Liberia Madagascar Mali Mauritania Nigeria Somalia South Sudan Togo Uganda Vanuatu

Countries with Rubella vaccine in the national immunization programme; and planned introductions in 2018 Introduced* to date: Albania Algeria Andorra Angola Antigua and Barbuda Argentina Armenia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Darussalam Bulgaria Burkina Faso Burundi Cabo Verde Cambodia Cameroon Canada Chile China Colombia Cook Islands Costa Rica Côte d'Ivoire Croatia Cuba Cyprus Czech Republic Denmark Dominica Dominican Republic Ecuador Egypt El Salvador Estonia Fiji Finland France Gambia Georgia Germany Ghana Greece Grenada Guatemala Guyana Haiti Honduras Hungary Iceland Iran (Islamic Republic of) Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Libya Lithuania Luxembourg Malawi Malaysia Maldives Malta Marshall Islands Mauritania Mauritius Mexico Micronesia (Federated States of ) Monaco Mongolia Montenegro Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Zealand Nicaragua Niue Norway Oman Palau Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Qatar Republic of Korea Republic of Moldova Romania Russian Federation Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Singapore Slovakia Slovenia Solomon Islands Spain Sri Lanka Suriname Swaziland Sweden Switzerland Syrian Arab Republic Tajikistan Thailand The former Yugoslav Republic of Macedonia Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Tuvalu Ukraine United Arab Emirates United Kingdom United Republic of Tanzania United States of America Uruguay Uzbekistan Vanuatu Venezuela Viet Nam Yemen Zambia Zimbabwe Partial introductions: India Indonesia Planned introductions in 2018: Benin Congo Eritrea Not Available, Not Introduced/No Plans: Afghanistan Central African Republic Chad Comoros Democratic People's Republic of Korea Democratic Republic of the Congo Djibouti Equatorial Guinea Ethiopia Gabon Guinea Guinea-Bissau Liberia Madagascar Mali Niger Nigeria Pakistan Sierra Leone Somalia South Africa South Sudan Sudan Uganda

Hepatitis B Birth dose (HepB-BD) vaccination strategies by country HepB-BD introduced to date: Afghanistan Albania Algeria Andorra Angola Argentina Armenia Australia Azerbaijan Bahrain Belarus Bhutan Bosnia and Herzegovina Botswana Brazil Brunei Darussalam Bulgaria Cabo Verde Cambodia China Colombia Cook Islands Costa Rica Cuba Democratic People’s Republic of Korea (the) Djibouti Dominica Dominican Republic (the) Ecuador Egypt El Salvador Estonia Fiji Gambia (the) Georgia Grenada Guatemala Honduras India Indonesia Iran (Islamic Republic of) Iraq Israel Kazakhstan Kiribati Kuwait Kyrgyzstan Lao People’s Democratic Republic (the) Lebanon Libya Lithuania Malaysia Maldives Marshall Islands (the) Mauritania Mexico Micronesia (Federated States of) Mongolia Morocco Myanmar Namibia Nauru Nigeria Niue Oman Palau Panama Papua New Guinea Paraguay Peru Philippines (the) Poland Portugal Qatar Republic of Korea (the) Republic of Moldova (the) Romania Russian Federation (the) Saint Kitts and Nevis Saint Vincent and the Grenadines Samoa Saudi Arabia Senegal Serbia Singapore Solomon Islands Spain Suriname Syrian Arab Republic (the) Tajikistan Thailand The former Yugoslav Republic of Macedonia Timor-Leste Tonga Tunisia Turkey Turkmenistan Tuvalu Ukraine United Arab Emirates (the) United States of America (the) Uzbekistan Vanuatu Venezuela (Bolivarian Republic of) Viet Nam HepB-BD only for infants born to HBsAG-positive mothers Belgium Chile Czech Republic (the) Denmark France Italy Latvia Luxembourg Monaco Netherlands (the) New Zealand Norway Saint Lucia Sao Tome and Principe Slovakia Slovenia Sweden Switzerland United Kingdom of Great Britain and Northern Ireland (the) HepB in schedule but no HepB-BD Antigua and Barbuda Austria Bahamas (the) Bangladesh Barbados Belize Benin Bolivia (Plurinational State of) Burkina Faso Burundi Cameroon Canada Central African Republic (the) Chad Comoros (the) Congo (the) Côte d'Ivoire Croatia Cyprus Democratic Republic of the Congo (the) Equatorial Guinea Eritrea Ethiopia Gabon Germany Ghana Greece Guinea Guinea-Bissau Guyana Haiti Hungary Ireland Jamaica Japan Jordan Kenya Lesotho Liberia Madagascar Malawi Mali Malta Mauritius Montenegro Mozambique Nepal Nicaragua Niger (the) Pakistan Rwanda San Marino Seychelles Sierra Leone Somalia South Africa South Sudan Sri Lanka Sudan (the) Swaziland Togo Trinidad and Tobago Uganda United Republic of Tanzania (the) Uruguay Yemen Zambia Zimbabwe HepB given only for risk groups or adolescents Finland Iceland

Countries with Mumps containing vaccine in the national immunization programme Introduced* to date: Albania Algeria Andorra Antigua and Barbuda Argentina Armenia Australia Austria Azerbaijan Bahamas Bahrain Barbados Belarus Belgium Belize Bhutan Bolivia Bosnia and Herzegovina Brazil Brunei Darussalam Bulgaria Cabo Verde Canada Chile China Colombia Cook Islands Costa Rica Croatia Cuba Cyprus Czech Republic Denmark Dominica Dominican Republic Ecuador Egypt El Salvador Estonia Finland France Georgia Germany Greece Grenada Guatemala Guyana Honduras Hungary Iceland Iran (Islamic Republic of) Iraq Ireland Israel Italy Jamaica Jordan Kazakhstan Kuwait Kyrgyzstan Latvia Lebanon Libya Lithuania Luxembourg Malaysia Maldives Malta Marshall Islands Mauritius Mexico Micronesia (Federated States of ) Monaco Mongolia Montenegro Netherlands New Zealand Nicaragua Niue Norway Oman Palau Panama Paraguay Peru Philippines Poland Portugal Qatar Republic of Korea Republic of Moldova Romania Russian Federation Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa San Marino Saudi Arabia Serbia Seychelles Singapore Slovakia Slovenia Spain Sri Lanka Suriname Sweden Switzerland Syrian Arab Republic Thailand The former Yugoslav Republic of Macedonia Trinidad and Tobago Turkey Turkmenistan Ukraine United Arab Emirates United Kingdom United States of America Uruguay Uzbekistan Venezuela Partial introductions: Planned introductions in 2018: Not Available, Not Introduced/No Plans: Afghanistan Angola Bangladesh Benin Botswana Burkina Faso Burundi Cambodia Cameroon Central African Republic Chad Comoros Congo Côte d'Ivoire Democratic People's Republic of Korea Democratic Republic of the Congo Djibouti Equatorial Guinea Eritrea Ethiopia Fiji Gabon Gambia Ghana Guinea Guinea-Bissau Haiti India Indonesia Japan Kenya Kiribati Lao People's Democratic Republic Lesotho Liberia Madagascar Malawi Mali Mauritania Morocco Mozambique Myanmar Namibia Nauru Nepal Niger Nigeria Pakistan Papua New Guinea Rwanda Sao Tome and Principe Senegal Sierra Leone Solomon Islands Somalia South Africa South Sudan Sudan Swaziland Tajikistan Timor-Leste Togo Tonga Tunisia Tuvalu Uganda United Republic of Tanzania Vanuatu Viet Nam Yemen Zambia Zimbabwe

Introduction of Varicella Containing Vaccines in National Immunization Programmes Introduced* to date: Andorra Argentina Australia Austria Bahamas Bahrain Barbados Brazil Canada Colombia Costa Rica Cyprus Ecuador Finland Germany Greece Israel Italy Japan Latvia Luxembourg Niue Oman Panama Paraguay Qatar Republic of Korea Saudi Arabia Spain Switzerland Turkey United Arab Emirates United States of America Uruguay Partial introductions: Antigua and Barbuda Russian Federation Introduced for risk groups: Grenada Guyana Iran (Islamic Republic of) Kuwait Mexico New Zealand Saint Lucia San Marino Slovenia Trinidad and Tobago United Kingdom Not Available, Not Introduced/No Plans: Afghanistan Albania Algeria Angola Armenia Azerbaijan Bangladesh Belarus Belgium Belize Benin Bhutan Bolivia Bosnia and Herzegovina Botswana Brunei Darussalam Bulgaria Burkina Faso Burundi Cabo Verde Cambodia Cameroon Central African Republic Chad Chile China Comoros Congo Cook Islands Côte d'Ivoire Croatia Cuba Czech Republic Democratic People's Republic of Korea Democratic Republic of the Congo Denmark Djibouti Dominica Dominican Republic Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji France Gabon Gambia Georgia Ghana Guatemala Guinea Guinea-Bissau Haiti Honduras Hungary Iceland India Indonesia Iraq Ireland Jamaica Jordan Kazakhstan Kenya Kiribati Kyrgyzstan Lao People's Democratic Republic Lebanon Lesotho Liberia Libya Lithuania Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Micronesia (Federated States of ) Monaco Mongolia Montenegro Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Nicaragua Niger Nigeria Norway Pakistan Palau Papua New Guinea Peru Philippines Poland Portugal Republic of Moldova Romania Rwanda Saint Kitts and Nevis Saint Vincent and the Grenadines Samoa Sao Tome and Principe Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Solomon Islands Somalia South Africa South Sudan Sri Lanka Sudan Suriname Swaziland Sweden Syrian Arab Republic Tajikistan Thailand The former Yugoslav Republic of Macedonia Timor-Leste Togo Tonga Tunisia Turkmenistan Tuvalu Uganda Ukraine United Republic of Tanzania Uzbekistan Vanuatu Venezuela Viet Nam Yemen Zambia Zimbabwe

Countries and Territories using Yellow fever* vaccine to date Introduced to date: Angola Benin Bolivia Brazil Burkina Faso Cameroon Central African Republic Chad Colombia Congo Côte d'Ivoire Democratic Republic of the Congo Ecuador Equatorial Guinea French Guyana Gabon Gambia Ghana Guinea Guinea-Bissau Guyana Liberia Mali Niger Nigeria Paraguay Peru Senegal Sierra Leone Suriname Togo Trinidad and Tobago Venezuela Sao Tome and Principe Seychelles introduced but are not listed as at risk countries. Introduced in High risk areas: Argentina Kenya Panama At risk but not introduced: Burundi Ethiopia Mauritania South Sudan Sudan Uganda

Countries and Territories using JE vaccine to date At risk countries/areas but not introduced: Bangladesh Bhutan Brunei Darussalam Democratic People's Republic of Korea Pakistan Papua New Guinea Philippines Russian Federation (Primorsky Kray) Singapore Timor-Leste Introduced to date: Cambodia China Japan Lao People's Democratic Republic Myanmar Nepal Republic of Korea Sri Lanka Thailand Viet Nam Introduced in the high risk areas: Australia (Cook) Introduced in parts of the country: India Indonesia Malaysia